Aside from the obvious economic challenges which all of us face thanks to our “transitory” inflation this is how we compare to the largest public orthopedic (some spine as well) companies (one year data June 16 2021 to June 16 2022 (percentage gains or losses)
1. zbh -32,31 percent
2. Stryker -21.02
3. J and j 2.25 gain (yes they are more diversified)
4 smith nephew -34.59
5. Medtronic -28.53
6. Djo -spin off can’t include
7. Nuvasive -24.97
8. Globus med -23.23
9 medacta -20.74
we beat smith nephew!
Now let’s look at 5 years data
1 zbh -5.87
2 Stryker 59.36 gain
3 Johnson and Johnson 34.05 gain
4 smith nephew -10.93
5 medtroinic 9.04 gain
6 djo was colfax recently spun out can’t list
7 nuvasive -30.62
8 globus medical 86.89 gain
9 medacta went ipo in 19 so no five year
we beat smith nephew
Glaring piece is Stryker up 59.36 while we are down 5.87 I guess winning is beating s and n.
1. zbh -32,31 percent
2. Stryker -21.02
3. J and j 2.25 gain (yes they are more diversified)
4 smith nephew -34.59
5. Medtronic -28.53
6. Djo -spin off can’t include
7. Nuvasive -24.97
8. Globus med -23.23
9 medacta -20.74
we beat smith nephew!
Now let’s look at 5 years data
1 zbh -5.87
2 Stryker 59.36 gain
3 Johnson and Johnson 34.05 gain
4 smith nephew -10.93
5 medtroinic 9.04 gain
6 djo was colfax recently spun out can’t list
7 nuvasive -30.62
8 globus medical 86.89 gain
9 medacta went ipo in 19 so no five year
we beat smith nephew
Glaring piece is Stryker up 59.36 while we are down 5.87 I guess winning is beating s and n.